rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
2006-5-31
|
pubmed:abstractText |
Interstitial lung disease (ILD) is a serious adverse effect of gefitinib, but its prevalence and risk factors remain largely unknown. We examined the prevalence of and risk factors for gefitinib-induced ILD associated with practical use of the drug in Japanese with non-small-cell lung cancer (NSCLC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1527-7755
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2549-56
|
pubmed:meshHeading |
pubmed-meshheading:16735708-Adult,
pubmed-meshheading:16735708-Aged,
pubmed-meshheading:16735708-Antineoplastic Agents,
pubmed-meshheading:16735708-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16735708-Female,
pubmed-meshheading:16735708-Humans,
pubmed-meshheading:16735708-Incidence,
pubmed-meshheading:16735708-Japan,
pubmed-meshheading:16735708-Lung Diseases, Interstitial,
pubmed-meshheading:16735708-Lung Neoplasms,
pubmed-meshheading:16735708-Male,
pubmed-meshheading:16735708-Middle Aged,
pubmed-meshheading:16735708-Multivariate Analysis,
pubmed-meshheading:16735708-Predictive Value of Tests,
pubmed-meshheading:16735708-Prognosis,
pubmed-meshheading:16735708-Proportional Hazards Models,
pubmed-meshheading:16735708-Quinazolines,
pubmed-meshheading:16735708-Retrospective Studies,
pubmed-meshheading:16735708-Risk Factors,
pubmed-meshheading:16735708-Sex Factors,
pubmed-meshheading:16735708-Smoking,
pubmed-meshheading:16735708-Survival Analysis,
pubmed-meshheading:16735708-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib.
|
pubmed:affiliation |
Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan. mando@kuhp.kyoto-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|